Compounded or confused? Bioidentical hormones and menopausal health

Menopause International

Volumn 17, Issue 1, 2011, Pages 16-18

  Huntley, Alyson L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

bioidentical hormones; menopause; treatment choice

Indexed keywords

COMPOUNDED BIOIDENTICAL HORMONE; CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; HORMONE DERIVATIVE; PRASTERONE; PROGESTERONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; BIOIDENTICAL HORMONE REPLACEMENT THERAPY; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SAFETY; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; HUMAN; MEDICAL INFORMATION; MENOPAUSAL SYNDROME; MENOPAUSE; PATIENT EDUCATION; PATIENT PREFERENCE; REVIEW; SALIVA ANALYSIS; WOMEN'S HEALTH;

DRUG COMPOUNDING; ESTROGEN REPLACEMENT THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; PATIENT EDUCATION AS TOPIC; PHYTOSTEROLS; PLANT PREPARATIONS; THERAPEUTIC EQUIVALENCY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WOMEN'S HEALTH;

EID: 79953199754     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1258/mi.2011.011009     Document Type: Review

References (14)

1. Anderson GL, Limacher M, Assaf AR,, et al. Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33
2. Ni H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care 2002; 40: 353–358
3. Hill-Sakurai L, Muller J, Thom DH. Complementary and alternative medicine for the menopause: a qualitative analysis of women's decision making. J Gen Intern Med 2008; 23: 619–22
4. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms: qualitative study of women's experiences. Can Fam Physician 1998; 44: 1271–6
5. Adams C, Cannell S. Women's beliefs about “natural” hormones and natural hormone replacement therapy. Menopause 2001; 8: 433–40
6. See www.johnleemd.com ( last checked 4 February 2011)
7. No authors. Compounded hormone therapies: unproven, untested- and popular. Endocrine Today. Posted 25 March 2008. See http//endocrinetoday.com ( last checked 4 February 2011)
8. FDA Center for Drug Evaluation and Research. Report: Limited FDA survey of compounded drug products (2003). See www.fda.gov/cder/pharmcomp/survey.htm ( last checked 4 February 2011).
9. Mahaguna V, McDermott JM, Zhang F, Ochoa F. Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel. Drug Dev Ind Pharm 2004; 30: 1069–78
10. Fugh-Bergman A, Bythrow J. Bioidentical hormones for menopausal hormone therapy: variations on a theme. JGIM 2007; 22: 1030–34
11. Boothby LA, Doering PL, Kipersztok S. Bioidentical hormone therapy: a review. Menopause 2004; 11: 356–67
12. Stanczyk FZ, Paulson RJ, Roy S. Percutaneous administration of progesterone: blood levels and endometrial protection. Menopause 2005; 12: 232–237
13. No authors. Bioidentical hormones. Med Lett Drug Ther 2010; 52: 43–44
14. No authors. What are bioidentical hormones? Harvard Women's Health Watch, August 2006. See http://www.health.harvard.edu/women ( last checked 4 February 2011)